Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Dr Ted Mikuls on Gout Study: BMI Was Independent of Amputation Rate
February 11th 2022Ted Mikuls, MD, MSPH, Stokes-Shackleford professor of rheumatology, vice chair for research, internal medicine at the University of Nebraska, explains how lower extremity amputation among US veterans with gout was independent of body mass index (BMI) and other risk factors.
Read More
Dr Kenneth Cohen on Education, Tools to Reduce Low-Value Care
February 10th 2022Kenneth Cohen, MD, FACP, executive director of clinical research at UnitedHealth Group Research and Development and senior national medical director at OptumCare, discusses evidence-based education and other tools to address low-value care.
Read More
Updates to American College of Rheumatology's COVID-19 Vaccine Guidelines for RMD
February 9th 2022Version 5 of “COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases" includes updated recommendations that differentiate supplemental and booster doses for people with rheumatic and musculoskeletal diseases (RMDs).
Read More
Dr Steven Pergam on Booster Vaccines for Patients With Cancer
February 8th 2022Steven Pergam, MD, MPH, director of infection prevention at Seattle Cancer Care Alliance and infectious disease physician at Fred Hutchinson Cancer Research Center, discusses delayed booster vaccines and potential fourth doses for people who are immunosuppressed.
Read More
Study Finds Higher In-Hospital Mortality Risk for Older Patients With Frailty, COVID-19
February 5th 2022Research showed that younger and nonfrail patients with COVID-19 were more likely to be put on a ventilator, while patients with frailty and older age had a higher risk of in-hospital and in-ICU mortality.
Read More
Use of Multiple Targeted Therapies for RA Linked to Herpes Zoster Risk, Study Finds
February 4th 2022Patients with rheumatoid arthritis (RA) who used 3 or more targeted therapies, but not Janus kinase inhibitors, were at greater risk of developing herpes zoster, according to findings from a Korean study.
Read More
Dr Ted Mikuls Discusses Study on Gout, Amputation Rates in Veterans
February 3rd 2022Ted Mikuls, MD, MSPH, Stokes-Shackleford professor of rheumatology, vice chair for research, internal medicine at the University of Nebraska, discusses his study comparing rates of lower extremity amputations in US veterans with and without gout, using data from the national Veterans Health Administration.
Read More
GPBCH Speakers Support Potential Benefit Design for Obesity
January 25th 2022Speakers at the Greater Philadelphia Business Coalition on Health (GPBCH) discussed data on lifestyles, economic trends, and presented real-life examples of obesity treatment, as well as a benefit design for obesity.
Read More
Refining Serological Weight Scoring to Increase RA Classification Specificity
January 25th 2022After analyzing past studies and classification criteria, authors found multiple factors that could be implemented into the current rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) tests for a more specific rheumatoid arthritis (RA) classification.
Read More
Study Highlights Health, Economic Benefits of RSV Vaccine for Older Adults
January 19th 2022With no existing respiratory syncytial virus (RSV) vaccine yet, researchers found that a vaccine comparable with the influenza vaccine could prevent tens of thousands of hospitalizations and deaths per year.
Read More
Dr Kenneth Cohen Discusses COVID-19 Impact on Low-Value Care
January 17th 2022Kenneth Cohen, MD, FACP, executive director of clinical research at UnitedHealth Group Research and Development and senior national medical director at OptumCare, explains why low-value care still exists and how the COVID-19 pandemic has affected the issue.
Read More